about
In situ imaging of metals in cells and tissuesSynthesis, cytotoxic and hydrolytic studies of titanium complexes anchored by a tripodal diamine bis(phenolate) ligand.Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.Water-soluble molybdenocene complexes with both proliferative and antiproliferative effects on cancer cell lines and their binding interactions with human serum albumin.Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.The addition of a pregnenolone pendant group enhances the anticancer properties of titanocene dichloride in a mcf-7 xenograft model.Titanium salan complexes displays strong antitumor properties in vitro and in vivo in micePharmaceutical formulation affects titanocene transferrin interactions.In Search for Titanocene Complexes with Improved Cytotoxic Activity: Synthesis, X-Ray Structure, and Spectroscopic Study of Bis(eta-cyclopentadienyl)difluorotitanium(IV).Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNAObserved hydrolysis of fluorine substituted bis(β-diketonato)-dichlorotitanium(IV) complexes.Synthesis and cytotoxicity studies of steroid-functionalized titanocenes as potential anticancer drugs: sex steroids as potential vectors for titanocenes.On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapyComparative In Vitro Binding Studies of TiCl2(dpme)2, Ti(ada)2(bzac)2, and TiCl2(bzac)(bpme) Titanium Complexes with Calf-Thymus DNA.Spectroscopic and Thermal Characterization of the Host-Guest Interactions between α-, β-, and γ-cyclodextrins and vanadocene dichloride.Synthesis, spectral characterization, and antiproliferative studies of mixed ligand titanium complexes of adamantylamine.Hyphenated techniques as tools for speciation analysis of metal-based pharmaceuticals: developments and applications.Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives.Metallocenes as Target Specific Drugs for Cancer Treatment.Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay.Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.Titanocene anticancer complexes and their binding mode of action to human serum albumin: a computational study.Cytotoxic properties of titanocenyl amides on breast cancer cell line mcf-7.Anticancer activity and mode of action of titanocene C.Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.Synthesis and cytotoxicity studies of titanocene C analoguesStudies of the Antiproliferative Activity of Ruthenium (II) Cyclopentadienyl-Derived Complexes with Nitrogen Coordinated Ligands.New tungstenocenes containing 3-hydroxy-4-pyrone ligands: antiproliferative activity on HT-29 and MCF-7 cell lines and binding to human serum albumin studied by fluorescence spectroscopy and molecular modeling methodsNanotoxicology and Metalloestrogens: Possible Involvement in Breast CancerDNA electrochemical biosensor for metallic drugs at physiological conditions.A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand."In vitro" comparative immune effects of different titanium compounds.Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
P2860
Q28662002-90A9830C-6F8C-4C52-B9CE-C247E60F5380Q30863652-8370DD66-457D-4151-9AA7-A95C3D6E4A92Q31147279-A6299D8D-0461-46C7-BAB7-EAE35172F637Q33470372-F9305A1F-11E0-459A-852E-C32106CC54A0Q33505885-7F1E759A-DC7B-4FD9-AF44-9674E90A4757Q33741578-CFEE3011-D061-426B-9DBB-6AD46E03DC35Q33857149-B2416D72-A2D4-4AE6-BDC3-9A0CC3EB587AQ33994647-E8F24BD5-4811-4A02-B71E-820F3966DE3CQ34003025-7E02128E-D1FD-4D9F-963D-A9EFA57B3CCBQ35489393-9E2F8DAF-197E-4009-BD57-008B619CEF9EQ35559053-204DE35B-35FC-48A4-AB49-8408FECF7C5BQ35705826-D15B6A72-F7F0-4E24-BA7A-3A2FF0D7432DQ36107216-6B54E493-A2C4-4E40-93CB-8ACA1DD6254DQ36457231-B5FD9792-9496-4771-AC50-FF4FA3C41B83Q37405050-942A253D-66B3-4499-A5B8-2218EF3B71B7Q37639884-45698B6C-9E20-4F1F-9705-18F34890D636Q38000483-7280C64A-7C46-41D1-A78F-23B0660B5628Q38011150-30A1A1FE-FEC7-4076-A0F3-D33C4086FEBEQ38062521-C484774A-A250-4668-990E-2A3D1C5848C0Q38763409-103BAD74-116F-449F-9F9D-CAD516275A97Q38795822-65334274-2175-4C89-BFE7-2A1C921D9720Q38827449-7DC201A7-B10F-4472-BC04-B3B4E261D7B8Q38827745-5B92A2D4-21AC-42CC-B2A6-6F236D647E6DQ39010679-8ADB63E7-05BE-46C9-9081-CB7BF465B4EEQ39282611-9112A1F1-D48F-4848-8554-4E08DDD4CAD0Q39409301-EBEB2723-4FB7-4E96-94F0-59965FF4A584Q39444431-06059667-5EC2-4CAF-9411-B3CBDCF085DEQ39483013-65C70110-2711-4E3C-90B7-5889CC966DFDQ39611571-24EE0765-DEBC-482B-9416-70591ED8318FQ39705944-6E12E99C-BBB0-47D4-9ED6-F85821CEBCBFQ39738480-3C39453C-5653-4C21-805C-F7A96A94A9A7Q39747437-6066CB60-AF9F-4A99-B626-4314B6BD026AQ40013205-94ABC8BC-749E-47D7-BC5C-FBCAD1858508Q42109757-B082FB50-7194-40D4-9AA1-D8E7A18C6646Q42160954-EC29FC69-ADD9-4764-8466-9D72C5331230Q42361372-A03F38E7-FE5F-4B40-BED9-2E4170441314Q42556236-7693BF41-94C7-43E4-9375-0019F4BDDB0AQ43930810-EB626629-9E3D-4DF3-B9E5-EB3B438943F7Q45042136-242247A9-8D96-4A0F-8B4A-28FAB4BD1830Q46345511-F628A7DA-40FC-4D51-B4AF-C4747CD61F61
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Titanium complexes in cancer treatment.
@ast
Titanium complexes in cancer treatment.
@en
Titanium complexes in cancer treatment.
@nl
type
label
Titanium complexes in cancer treatment.
@ast
Titanium complexes in cancer treatment.
@en
Titanium complexes in cancer treatment.
@nl
prefLabel
Titanium complexes in cancer treatment.
@ast
Titanium complexes in cancer treatment.
@en
Titanium complexes in cancer treatment.
@nl
P1476
Titanium complexes in cancer treatment.
@en
P2093
Enrique Meléndez
P304
P356
10.1016/S1040-8428(01)00224-4
P577
2002-06-01T00:00:00Z